squeezekid
0Jun 10
$RXRX working hard!
The Company now expects its projected cash runway to extend into the fourth quarter of 2027. These changes are expected to result in a workforce reduction of approximately 20%. BULLISH.
The Company has the potential to receive
over $100 million in cash inflows from progress-based milestone payments from partners by the end of 2026. BULLISH.
The Company expects cash, cash equivalents and restricted cash for the quarter ending June 30, 2025 to be above $500 million compared to $509 million as of the quarter ending March 31, 2025. BULLISH.
This estimate is based on impacts from streamlining of operations, receipt of a one-time $28 million R&D tax credit, partnership inflows and utilization of the Company’s at-the-market offering program, offset by one-time severance payments. BULLISH.
https://ir.recursion.com/static-files/a12facdf-e0bc-4edd-aa1d-d2cb823d0af9
👍
44
11098 views
Comments (10)
🎉
Jun 10
Tipped 500 coins
💎
Jun 10
Tipped 200 coins
Jun 10
Tipped 2800 coins
Jun 10
They have no product yet, that’s why they’re thinning. They haven’t discovered a product or drug that can make them revenue.
Firing 20% of their workforce makes it 20% less likely that they will find it.
💯
10
❤️
4
Jun 10
My broker doesn't have it 😭
💎
Jun 10
Im gonna say $6, call 6/23 $15 contracts . Than me later
Jun 10
So they are firing 20% of their employees to be able to survive until 2027. They have not received the $100 million because they have yet to meet the milestones, and their cash cushion has decreased despite getting a $28 million tax credit.
🚀
10
Jun 10
EMA & SMA back to uptrend stack as well, last time was in Feb. Hoping RXRX stays back on a positive track. Long play with big future potential. Thanks @squeezekid